NAVIGATION
 
> OPPI Vision
> Office Bearers 
> Committees
> News and Events
> OPPI in Media - 2010 to date - News at a glance
> OPPI Position on IPR
> Pharma Spectrum - Monthly News At A Glance
> OPPI Position Paper on Biosimilars
> OPPI Position on Data Protection
> OPPI Anti - Counterfeiting Guidelines
> A Handy Guide for Road Safety
> OPPI IPR Symposium Videos
> Patents
> Drug Policy & Pricing
> Regulatory
> Links
> India OTC Pharmaceutical Profile 2011
 

 

IFPMA Clinical
Trials Portal

IFPMA - Improving
Global Health


OPPI Guidelines on
Cold Chain
Pharmaceutical Products


OPPI - YES Bank Report,
Pharmaceutical Industry:
Vision 2015


OPPI IPR
Symposium Proceedings

 
About Us Members Publications Contact Us Member Login

The Organisation of Pharmaceutical Producers of India (OPPI) established in 1965 is a premier association of research based international and large pharmaceutical companies in India and is also a scientific and professional body.
OPPI is affiliated with IFPMA
OPPI 45th Annual
Report 2010-11



Click Here
 India emerging
(OPPI and E&Y Report)



Click here

Transforming Life Sciences Logistics in India
(OPPI & DHL Report)


Click Here
 
 




Ranjit Shahani
President

 
Should FDI in pharma be restricted?

Tapan Ray, Director General, OPPI
 The Financial Express, Oct 7, 2011
  


 

Tapan Ray
Director General
 
 

OPPI Code of Pharmaceutical Marketing Practices 2010


Click Here
 		 Mr. Andrew Witty, CEO, GSK
Chief Guest, OPPI 45th AGM
 

Click here for Video speech		  OPPI Code on Conduct
of Clinical Trials

 
Click Here
 
  

            Copyright © 2011. Organisation of Pharmaceutical Producers of India. All Rights Reserved.  |   Disclaimer  |